CDK4/6 inhibitors for HER2-positive ABC require further investigation; however, CDK4/6 inhibitors should be considered if metastases are rebiopsied and HER2-negative conversion occurs during treatment. Here, ERBB2 is linked to aneurysmal bone cyst.